{"transactions":[{"id":689155,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":24079,"kind":"person","name":"Pauls Dietrich John","position":1,"cik":"0001760123","reported_name":"Pauls Dietrich John","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Voting Common Shares, no par value per share","published_at":"2026-08-12T20:23:41.000Z","date":"2026-08-10","kind":"grant","planned":false,"acquired":true,"shares":60200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units will vest in four equal installments, each on the first, second, third, and fourth anniversaries of the grant date, provided, however, that the participant remains continuously employed by or provides services to the Company, or one of its Subsidiaries or Affiliates, through the applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,749 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan."}],"balance_after":128791,"source":{"system":"sec-edgar","filing":"0001760123-26-000004","document":"form4-08122026_080836.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000176012326000004/form4-08122026_080836.xml","form_type":"4"}},{"id":751410,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":24079,"kind":"person","name":"Pauls Dietrich John","position":1,"cik":"0001760123","reported_name":"Pauls Dietrich John","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (right to buy)","published_at":"2026-06-03T21:23:45.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":380000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Scheduled to vest with respect to 25% of the shares on the one-year anniversary of the grant date, with the remaining shares scheduled to vest in twelve equivalent quarterly installments."}],"balance_after":380000,"derivative":{"exercise_price":5.84,"expiration_date":"2036-06-01","underlying":"Voting Common Shares","underlying_shares":380000},"source":{"system":"sec-edgar","filing":"0001760123-26-000002","document":"form4-06032026_090640.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000176012326000002/form4-06032026_090640.xml","form_type":"4"}},{"id":1124621,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":24079,"kind":"person","name":"Pauls Dietrich John","position":1,"cik":"0001760123","reported_name":"Pauls Dietrich John","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Stock Option (right to buy)","published_at":"2025-06-03T20:18:01.000Z","date":"2025-06-01","kind":"grant","planned":false,"acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests with respect to 25% of the underlying common shares on June 1, 2026 with the remaining 75% of the underlying common shares vesting quarterly over the following three years commencing on September 1, 2026."}],"balance_after":600000,"derivative":{"exercise_price":4.11,"expiration_date":"2035-05-31","underlying":"Common Shares","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001437749-25-019294","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000143774925019294/rdgdoc.xml","form_type":"4"}},{"id":1494976,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":24079,"kind":"person","name":"Pauls Dietrich John","position":1,"cik":"0001760123","reported_name":"Pauls Dietrich John","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2024-06-03T20:41:13.000Z","date":"2024-06-01","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests with respect to 25% of the underlying common shares on June 1, 2025 and with respect to the remaining 75% of the underlying common shares vesting quarterly over the following three years commencing on September 1, 2025."}],"balance_after":300000,"derivative":{"exercise_price":2.9,"expiration_date":"2034-05-31","underlying":"Common Shares","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001235802-24-000050","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580224000050/primary_doc.xml","form_type":"4"}},{"id":1844119,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":24079,"kind":"person","name":"Pauls Dietrich John","position":1,"cik":"0001760123","reported_name":"Pauls Dietrich John","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Voting Common Shares, no par value per share","published_at":"2023-06-26T20:34:35.000Z","date":"2023-06-23","kind":"purchase","planned":false,"acquired":true,"shares":12787,"price":3.91,"value":49997.17,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,749 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan."}],"balance_after":68591,"source":{"system":"sec-edgar","filing":"0001235802-23-000072","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580223000072/primary_doc.xml","form_type":"4"}},{"id":1869423,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":24079,"kind":"person","name":"Pauls Dietrich John","position":1,"cik":"0001760123","reported_name":"Pauls Dietrich John","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock option (right to buy)","published_at":"2023-06-02T20:39:40.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":181000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests with respect to 25% of the underlying common shares on June 1, 2024 and with respect to the remaining 75% of the underlying common shares vesting quarterly over the following three years commencing on September 1, 2024."}],"balance_after":181000,"derivative":{"exercise_price":2.73,"expiration_date":"2033-05-31","underlying":"Common Shares","underlying_shares":181000},"source":{"system":"sec-edgar","filing":"0001235802-23-000061","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580223000061/primary_doc.xml","form_type":"4"}},{"id":2114396,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":24079,"kind":"person","name":"Pauls Dietrich John","position":1,"cik":"0001760123","reported_name":"Pauls Dietrich John","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Voting Common Shares, no par value per share","published_at":"2022-11-17T01:56:42.000Z","date":"2022-11-16","kind":"purchase","acquired":true,"shares":20000,"price":1.21,"value":24200.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $1.17 to $1.21, inclusive.  The reporting person undertakes to provide to DiaMedica Therapeutics Inc., any security holder of DiaMedica Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,749 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan."}],"balance_after":55804,"source":{"system":"sec-edgar","filing":"0001235802-22-000121","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580222000121/primary_doc.xml","form_type":"4"}},{"id":2247265,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":24079,"kind":"person","name":"Pauls Dietrich John","position":1,"cik":"0001760123","reported_name":"Pauls Dietrich John","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2022-06-02T21:06:36.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":177000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests with respect to 25% of the underlying common shares on June 1, 2023 and with respect to the remaining 75% of the underlying common shares in 36 as nearly equal as possible monthly installments commencing on July 1, 2023."}],"balance_after":177000,"derivative":{"exercise_price":2.45,"expiration_date":"2032-05-31","underlying":"Common Shares","underlying_shares":177000},"source":{"system":"sec-edgar","filing":"0001235802-22-000076","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580222000076/primary_doc.xml","form_type":"4"}},{"id":2602149,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":24079,"kind":"person","name":"Pauls Dietrich John","position":1,"cik":"0001760123","reported_name":"Pauls Dietrich John","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Voting Common Shares, no par value per share","published_at":"2021-08-16T20:19:26.000Z","date":"2021-08-16","kind":"purchase","acquired":true,"shares":5000,"price":3.14,"value":15700.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $3.12 to $3.15, inclusive.  The reporting person undertakes to provide to DiaMedica Therapeutics Inc., any security holder of DiaMedica Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,749 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan."}],"balance_after":35804,"source":{"system":"sec-edgar","filing":"0001235802-21-000098","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580221000098/primary_doc.xml","form_type":"4"}},{"id":2622062,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":24079,"kind":"person","name":"Pauls Dietrich John","position":1,"cik":"0001760123","reported_name":"Pauls Dietrich John","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-07-30T01:07:43.000Z","date":"2021-07-28","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests in sixteen nearly equal quarterly installments over four years."}],"balance_after":175000,"derivative":{"exercise_price":5,"expiration_date":"2031-07-27","underlying":"Common Shares","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001235802-21-000092","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580221000092/primary_doc.xml","form_type":"4"}},{"id":3126748,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":24079,"kind":"person","name":"Pauls Dietrich John","position":1,"cik":"0001760123","reported_name":"Pauls Dietrich John","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-06-02T21:19:51.000Z","date":"2020-06-01","kind":"grant","acquired":true,"shares":56000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests in twelve nearly equal quarterly installments commencing on September 1, 2020."}],"balance_after":56000,"derivative":{"exercise_price":4.64,"expiration_date":"2030-05-31","underlying":"Common Shares","underlying_shares":56000},"source":{"system":"sec-edgar","filing":"0001235802-20-000053","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580220000053/primary_doc.xml","form_type":"4"}},{"id":3435969,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":24079,"kind":"person","name":"Pauls Dietrich John","position":1,"cik":"0001760123","reported_name":"Pauls Dietrich John","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Voting Common Shares, no par value per share","published_at":"2019-08-16T20:31:22.000Z","date":"2019-08-16","kind":"purchase","acquired":true,"shares":1000,"price":2.6769,"value":2676.9,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,749 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan."}],"balance_after":30804,"source":{"system":"sec-edgar","filing":"0001235802-19-000105","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580219000105/primary_doc.xml","form_type":"4"}},{"id":3477983,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":24079,"kind":"person","name":"Pauls Dietrich John","position":1,"cik":"0001760123","reported_name":"Pauls Dietrich John","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2019-06-26T20:42:35.000Z","date":"2019-06-24","kind":"grant","acquired":true,"shares":264000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests in eight equal quarterly installments over two years."}],"balance_after":264000,"derivative":{"exercise_price":4.6,"expiration_date":"2029-06-23","underlying":"Common Shares","underlying_shares":264000},"source":{"system":"sec-edgar","filing":"0001235802-19-000064","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580219000064/primary_doc.xml","form_type":"4"}},{"id":3735340,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":24079,"kind":"person","name":"Pauls Dietrich John","position":1,"cik":"0001760123","reported_name":"Pauls Dietrich John","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Voting Common Shares, no par value per share","published_at":"2018-12-11T21:31:11.000Z","date":"2018-12-11","kind":"purchase","acquired":true,"shares":5000,"price":4,"value":20000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,749 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan."}],"balance_after":29804,"source":{"system":"sec-edgar","filing":"0001235802-18-000182","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580218000182/primary_doc.xml","form_type":"4"}}]}